The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; MERCK; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis
Research Funding - AstraZeneca/MedImmune; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Ipsen
 
Alejo Rodriguez-Vida
No Relationships to Disclose
 
Ignacio Duran
Honoraria - Bristol-Myers Squibb; Ipsen; Roche/Genentech
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Simon J. Crabb
Honoraria - Janssen-Cilag; Novartis; Roche
Consulting or Advisory Role - Bayer; Clovis Oncology; Janssen-Cilag; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Clovis Oncology; Plexxikon
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck; Roche
 
Michiel Simon Van Der Heijden
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; MSD Oncology; Novartis
 
Albert Font Pous
No Relationships to Disclose
 
Gwenaelle Gravis
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; NOVARTIS; SANOFI; Takeda
 
Urbano Anido Herranz
Honoraria - Bayer; Novartis; Pfizer
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Astellas Pharma
 
Andrew Protheroe
No Relationships to Disclose
 
Alain Ravaud
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Denis Maillet
No Relationships to Disclose
 
Maria Jose Mendez-Vidal
No Relationships to Disclose
 
Cristina Suarez
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Pfizer; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Anja Lorch
Honoraria - Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; Ipsen
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Novartis; Novartis; Roche
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Cora N. Sternberg
Honoraria - Astellas Pharma; AstraZeneca; Ipsen; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Ferring; Janssen; Lilly; MSD; Novartis
 
Mark David Linch
No Relationships to Disclose
 
Shah-Jalal Sarker
No Relationships to Disclose
 
Aaron Prendergast
No Relationships to Disclose
 
Kelly Mousa
No Relationships to Disclose
 
Daniel E. Castellano
No Relationships to Disclose